The Swiss Medical Technology Industry 2010 Report

2010

The Swiss medical technology industry is entering a new phase. It will remain a strong growth industry, with companies in the industry anticipating annual growth of 10 to 12 percent over the next two years. However, the conditions in which this growth will take place have changed due to the global economic crisis: increased pressure on prices and costs in the healthcare markets, coupled with tougher international competition, is forcing Swiss medtech companies to rearrange their strategic priorities. Whereas strengthening product innovation was the top priority two years ago, improving profitability now occupies the top spot.

These are the findings of the Swiss Medical Technology Industry 2010 Survey, conducted in recent months by Medical Cluster in conjunction with Roland Berger Strategy Consultants and accounting and consulting firm Deloitte.